Neurology is referred to the study of diseases associated with the nervous system, which mainly comprise the brain, blood vessels, muscles, and nerves. Rapid technological improvements in neurological devices have provided relief to an unprecedented number of patients affected by neurological and psychiatric disorders. The major types of neurological devices include neurostimulation devices, neurosurgery devices, interventional neurology devices, cerebrospinal fluid management devices, and others. Furthermore, neurology devices such as neurostimulation devices make use of invasive and noninvasive methods that include the application of electrical stimulation to drive neural function within a circuit. These implantable devices target specific subcortical, cortical, spinal, cranial, and peripheral nerve structures to modify the neuronal activity, providing therapeutic effects for a myriad of neuropsychiatric disorders.

List of Key Players

Comprehensive competitive analysis and profiles of major market players such as Abbott Laboratories., B. Braun Melsungen AG, Boston Scientific Corporation., Integra LifeSciences Holdings Corporation, LivaNova PLC, Johnson & Johnson, Medtronic Plc., Magstim Co Ltd., Penumbra, Inc., and Stryker Corporation are provided in this report.

Download Sample Report: https://www.alliedmarketresearch.com/request-sample/6321

Neurology is referred to the study of diseases associated with the nervous system, which mainly comprise the brain, blood vessels, muscles, and nerves. Rapid technological improvements in neurological devices have provided relief to an unprecedented number of patients affected by neurological and psychiatric disorders. The major types of neurological devices include neurostimulation devices, neurosurgery devices, interventional neurology devices, cerebrospinal fluid management devices, and others. Furthermore, neurology devices such as neurostimulation devices make use of invasive and noninvasive methods that include the application of electrical stimulation to drive neural function within a circuit. These implantable devices target specific subcortical, cortical, spinal, cranial, and peripheral nerve structures to modify the neuronal activity, providing therapeutic effects for a myriad of neuropsychiatric disorders.

Rise in geriatric population across the globe, surge in disposable income in developing economies, improvement of healthcare infrastructure, and development of advanced technological devices for treatment & diagnosis of neurological disorders are the major factors that significantly contribute toward the growth of the global neurological market. Furthermore, surge in incidence of neurological disorders across the globe propels the market growth. However, implementation of stringent government regulations toward the approval of these devices and dearth of skilled neurosurgeons are the key factors anticipated to hamper the market growth. On the contrary, the introduction of new products and technological advancements have aided in efficient treatment of many neurovascular disorders, which is anticipated to create lucrative growth opportunities for the market during the forecast period.

By product, the cerebrospinal fluid management devices segment dominated the neurological devices market in 2018, and is anticipated to maintain its dominance during the forecast period. This is attributed to surge in usage of these devices for diagnosis of various neurological diseases. For instance, these management devices are widely being used for the diagnosis of diseases such as multiple sclerosis, myelitis, and encephalitis. 
By end user, the hospital segment accounted for the majority of market share in 2018, and is anticipated to continue the trend during the forecast period. This is attributed to easy availability of neurological devices in hospital settings and preference among patients to visit hospitals for effective diagnosis & treatment of neurological devices.

For Purchase inquiry: https://www.alliedmarketresearch.com/purchase-enquiry/6321

𝐀𝐛𝐨𝐮𝐭 𝐀𝐥𝐥𝐢𝐞𝐝 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of the domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Leave a comment

Your email address will not be published.